Synapse - Genitourinary Oncology Service

Search Within

Genitourinary Oncology Service

Results (5694)

Fatigue improvement/reduction with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel - Results from the COU-AA-301 phase 3 study

Meeting Abstract

Sternberg, C. N.; Scher, H. I.; Molina, A.; North, S.; Mainwaring, P.; Hao, Y.; Gagnon, D.; Kheoh, T.; Haqq, C. M.; de Bono, J.
European Journal of Cancer (2011)

Fulltext@MSK | Save

QT/QTc studies of abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC) - Analysis of 3 phase 1/2 studies

Meeting Abstract

Ryan, C. J.; Danila, D. C.; Tolcher, A.; Chi, K. N.; Tran, N.; Knoblauch, R.; Kheoh, T.; Haqq, C. M.; Scher, H. I.; Molina, A.
European Journal of Cancer (2011)

Fulltext@MSK | Save

Assessment of progression-free survival as a surrogate endpoint for overall survival in patients with metastatic renal cell carcinoma

Meeting Abstract

Negrier, S.; Bushmakin, A. G.; Cappelleri, J. C.; Charbonneau, C.; Sandin, R.; Michaelson, M. D.; Figlin, R. A.; Motzer, R. J.
European Journal of Cancer (2011)

Fulltext@MSK | Save

Prognostic factors for progression-free survival (PFS), overall survival (OS), and long-term OS (LT-OS) with sunitinib in 1,059 patients, treated on clinical trials, with metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Motzer, R. J.; Escudier, B.; Bukowski, R.; Rini, B. I.; Hutson, T. E.; Barrios, C. H.; Lin, X.; Fly, K.; Matczak, E.; Gore, M. E.
European Journal of Cancer (2011)

Fulltext@MSK | Save

Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy

Journal Article

Kaag, M. G.; Milowsky, M. I.; Dalbagni, G.; Thompson, R. H.; Katz, D.; Reuter, V. E.; Herr, H. W.; Bajorin, D.; Bochner, B. H.
BJU International (2011)

Fulltext@MSK | Save

Disseminated intravascular coagulation with excessive fibrinolysis in prostate cancer: A case series and review of the literature

Journal Article

Hyman, D. M.; Soff, G. A.; Kampel, L. J.
Oncology (2011)

Fulltext@MSK | Save

Abiraterone acetate improves functional status in patients with metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel - Results from the COU-AA-301 phase 3 study

Meeting Abstract

Harland, S.; de Bono, J. S.; Haqq, C. M.; Staffurth, J. N.; Hao, Y.; Gagnon, D.; Liu, C.; Sternberg, C. N.; Molina, A.; Scher, H. I.
European Journal of Cancer (2011)

Fulltext@MSK | Save

Final overall survival (OS) analysis of COU-AA-301, a phase 3 study of abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) pretreated with docetaxel

Meeting Abstract

Fizazi, K.; Scher, H. I.; Molina, A.; Logothetis, C. J.; Jones, R. J.; Staffurth, J. N.; Li, J.; Kheoh, T.; Haqq, C. M.; de Bono, J. S.
European Journal of Cancer (2011)

Fulltext@MSK | Save

Association of single nucleotide polymorphisms (SNPs) in VEGF pathway genes with progression-free survival (PFS) and blood pressure (BP) in metastatic renal cell carcinoma (mRCC) in the phase 3 trial of axitinib versus sorafenib (AXIS trial)

Meeting Abstract

Escudier, B.; Loomis, A. K.; Kaprin, A.; Motzer, R.; Tomczak, P.; Tarazi, J.; Kim, S.; Gao, F.; Williams, J. A.; Rini, B.
European Journal of Cancer (2011)

Fulltext@MSK | Save

Neutropenia and thrombocytopenia during treatment as biomarkers of sunitinib efficacy in patients with metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Donskov, F.; Carus, A.; Barrios, C. H.; Escudier, B.; Li, S.; Perkins, J.; Motzer, R. J.
European Journal of Cancer (2011)

Fulltext@MSK | Save